Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PCS Health Systems Inc.

Latest From PCS Health Systems Inc.

Merck/Medco Model Returns – At The PBM Management Level

Former tops execs at GSK and Lilly are going to try their hand at running PBMs. If they need advice, they can ask their predecessors from the 1990s, when big pharma ran the big three PBMs.

Pricing Debate Leadership

Healthy Convergence

Some health care firms have managed to work around the industry's well-documented growth constraints by pursuing a strategy of convergence--finding new combinations of formerly distinct market segments for pharmaceuticals, devices, and diagnostics. The authors, at Bain & Company, outline the considerations that drive the evaluation of and set the stage for convergence opportunities. Companies can use them to capitalize on an array of opportunities throughout the commercialization continuum and develop a response to potential threats from the outside.

BioPharmaceutical Medical Device

And You Thought Biotech Was Risky

Given the enormous proposed market caps on's and PlanetRx's IPOs, you could be forgiven for inferring that the Internet pharmacies are as close to a real business as anything to come out of Silicon Valley's dream factory. But you'd be wrong. Risks abound. And one big problem is access to reimbursed patients.'s costly deal with Rite Aid shows just how much the Internet pharmacy was willing to pay, both in terms of dilution and strategic flexibility, to get a solid connection with patients who have drug benefits.

Business Strategies Reimbursement

And Then There Was One

SB's decision to sell its DPS pharmacy benefit management business leaves Merck as the only drug company still owning its own PBM. It also creates a powerhouse PBM in the managed care marketplace.

Business Strategies Reimbursement
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services